| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/2014 | US8709450 Cellulose derivative and hydrogel thereof |
| 04/29/2014 | US8709395 Method for repairing or replacing damaged tissue |
| 04/29/2014 | US8709393 Methods and compositions for wound healing |
| 04/29/2014 | US8709385 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 04/29/2014 | US8709380 Targeting agents for enhancing radiation therapy |
| 04/29/2014 | US8709310 Spray drying vancomycin |
| 04/29/2014 | US8708966 Microneedle devices and methods of manufacture and use thereof |
| 04/29/2014 | US8708948 Intracoronary device and method of use thereof |
| 04/29/2014 | US8707962 Device for protecting an area of the human body |
| 04/29/2014 | CA2789115C Microporation of tissue for delivery of bioactive agents |
| 04/29/2014 | CA2775393C Topical non-aqueous pharmaceutical formulations |
| 04/29/2014 | CA2736596C External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 04/29/2014 | CA2704778C Formulations for enhanced bioavailability of orally administered polar agents |
| 04/29/2014 | CA2645629C Orodispersible domperidone tablets |
| 04/29/2014 | CA2585976C Novel composition for easing human childbirth |
| 04/29/2014 | CA2581196C Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/24/2014 | WO2014063122A1 Suppository insertion device, suppository, and method of manufacturing a suppository |
| 04/24/2014 | WO2014063101A1 Formulations of pyrimidinedione derivative compounds |
| 04/24/2014 | WO2014063087A1 Treating tumors of the central nervous system |
| 04/24/2014 | WO2014063071A1 Treatment of depression and ptsd |
| 04/24/2014 | WO2014062817A1 Topical steroid composition and method |
| 04/24/2014 | WO2014062689A1 Removable tattoo ink and the use thereof |
| 04/24/2014 | WO2014062566A1 Immunomodulation using spores and pollen grains |
| 04/24/2014 | WO2014062538A1 Polysaccharide-containing hydrogels, compositions, articles, and methods |
| 04/24/2014 | WO2014062494A1 Compositions and methods for the transdermal delivery of methylphenidate |
| 04/24/2014 | WO2014062446A1 Taste masked active pharmaceutical powder compositions and processes for making them |
| 04/24/2014 | WO2014062444A1 Solventless mixing process for coating pharmaceutical ingredients |
| 04/24/2014 | WO2014062059A1 Enhanced nail penetrating composition |
| 04/24/2014 | WO2014061838A1 Composition comprising leaf extract of dendropanax morbifera as active ingredient for treating and preventing bowl disease |
| 04/24/2014 | WO2014061332A1 Hyaluronic acid gel and method for producing same |
| 04/24/2014 | WO2014060988A2 Heating plaster for the treatment of punctures of jellyfish and other marine animals |
| 04/24/2014 | WO2014060952A1 Osmotic floating tablets |
| 04/24/2014 | WO2014060929A1 Chewing gums |
| 04/24/2014 | WO2014060857A1 Pharmaceutical compositions of diclofenac or salts thereof |
| 04/24/2014 | WO2014060856A1 Pharmaceutical compositions of diclofenac or salts thereof |
| 04/24/2014 | WO2014060855A1 Pharmaceutical compositions of diclofenac or salts thereof |
| 04/24/2014 | WO2014060792A1 Skin patch for absorbing toxins from the body |
| 04/24/2014 | WO2014060566A1 Beadlets comprising carotenoids |
| 04/24/2014 | WO2014060561A1 Oral pharmaceutical formulations comprising dabigatran |
| 04/24/2014 | WO2014060560A1 Solid oral formulations of prasugrel |
| 04/24/2014 | WO2014060554A1 Prasugrel formulations |
| 04/24/2014 | WO2014060545A1 Pharmaceutical compositions of dabigatran free base |
| 04/24/2014 | WO2014060472A1 Fatty acid acylated amino acids for oral peptide delivery |
| 04/24/2014 | WO2014060364A1 Sulfestrol for treating cancer |
| 04/24/2014 | WO2014060199A1 Solid oral composition containing dyes for use in endoscopic diagnosis |
| 04/24/2014 | WO2014060150A1 Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis |
| 04/24/2014 | WO2014060138A1 Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia |
| 04/24/2014 | WO2014059955A1 A solid oral pharmaceutical formulation containing ticagrelor |
| 04/24/2014 | WO2014059880A1 Method for preparation of pomegranate-peel polyphenol gel used to treat gynecological inflammation |
| 04/24/2014 | WO2014059748A1 Pharmaceutic osmotic pump preparation |
| 04/24/2014 | WO2014059649A1 Lycopene microcapsule preparation method |
| 04/24/2014 | WO2014059558A1 Durable analgetic sebacoyl dinalbuphine ester-plga controlled release formulation |
| 04/24/2014 | WO2014059512A1 Oral drug delivery formulations |
| 04/24/2014 | WO2014035206A3 Method for preparing microspheres for emboli, and method for preparing microspheres to which drug-containing carrier is bound |
| 04/24/2014 | WO2014028941A3 Adipose composition systems and methods |
| 04/24/2014 | WO2013092417A3 Active substance combinations of one or more alkyl ethers of glycerol and one or more physiologically acceptable hydroxamic acids, and cosmetic or dermatological preparations containing such active substance combinations |
| 04/24/2014 | WO2013038267A8 Tamper resistant pharmaceutical formulations |
| 04/24/2014 | WO2012140302A3 Method for manufacturing a microencapsulate of a hydrophobic ingredient and microencapsulate and corresponding compositions |
| 04/24/2014 | WO2012126005A3 Polymer hydrogels for in vivo applications and methods for using and preparing same |
| 04/24/2014 | WO2012116282A3 Protein nanocarriers for topical delivery |
| 04/24/2014 | WO2012116272A3 Polymer conjugated protein micelles |
| 04/24/2014 | WO2012115987A3 Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock |
| 04/24/2014 | WO2012068270A3 Enteric-coated sodium metabisulfite livestock feed additive for vomitoxin detoxification |
| 04/24/2014 | US20140114269 Novel wound dressing |
| 04/24/2014 | US20140113975 Biodegradable block copolymeric compositions for drug delivery |
| 04/24/2014 | US20140113965 Bronchodilating beta-agonist compositions and methods |
| 04/24/2014 | US20140113947 Pharmaceutical cream compositions of oxymetazoline and methods of use |
| 04/24/2014 | US20140113926 Process for the production of an abuse-proofed solid dosage form |
| 04/24/2014 | US20140113889 Treatment for dry eye |
| 04/24/2014 | US20140113888 Novel Combination of Therapeutic Agents |
| 04/24/2014 | US20140113865 Use of pertussis toxin as a therapeutic agent |
| 04/24/2014 | US20140113864 Injectable Depot Composition |
| 04/24/2014 | US20140113855 Modified Release Formulations for Oprozomib |
| 04/24/2014 | US20140113371 Cryopreservation of Haptenized Tumor Cells |
| 04/24/2014 | US20140112996 Dosage forms for oral administration and methods of treatment using the same |
| 04/24/2014 | US20140112995 Multi-layered, multiple unit pharmaceutical compositions |
| 04/24/2014 | US20140112994 Method for Making Medical Devices Having Antimicrobial Coatings Thereon |
| 04/24/2014 | US20140112993 Freeze-dried aripiprazole formulation |
| 04/24/2014 | US20140112990 Injectable Preformed Macroscopic 3-Dimensional Scaffolds for Minimally Invasive Administration |
| 04/24/2014 | US20140112989 Abuse-proofed oral dosage form |
| 04/24/2014 | US20140112988 Pharmaceutical Composition and Administrations Thereof |
| 04/24/2014 | US20140112987 Gastroresistant pharmaceutical formulations containing rifaximin |
| 04/24/2014 | US20140112986 Proliposomal testosterone formulations |
| 04/24/2014 | US20140112985 Method of prevention and treatment of clostridium difficile infection |
| 04/24/2014 | US20140112984 Crush resistant delayed-release dosage forms |
| 04/24/2014 | US20140112981 Controlled release hydrocodone formulations |
| 04/24/2014 | US20140112980 Abuse-resistant pharmaceutical compositions |
| 04/24/2014 | US20140112979 Methods for producing liposomes |
| 04/24/2014 | US20140112974 Ropinirole-containing patch and package thereof |
| 04/24/2014 | US20140112970 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 04/24/2014 | US20140112961 Methods and compositions for treating conditions related to lack of blood supply, shock, and neuronal injuries |
| 04/24/2014 | US20140112957 Analegisic (Sebacoyl dinalbuphine ester) PLGA controlled release formulation form |
| 04/24/2014 | US20140112906 Prostatic Acid Phosphatase for the Treatment of Pain |
| 04/24/2014 | US20140112900 Solubilized CoQ-10 |
| 04/24/2014 | US20140112874 Tape-type fluorine preparation using biodegradable polymer and method of preparing the same |
| 04/24/2014 | US20140109916 Transdermal Delivery of Hormones without the Need of Penetration Enhancers |
| 04/24/2014 | DE102012105512A1 Arzneiform zur verlängerten Freisetzung von Wirkstoffen Dosage form for the prolonged release of active ingredients |
| 04/23/2014 | EP2722058A1 Solid oral composition containing dyes for use in endoscopic diagnosis |
| 04/23/2014 | EP2722054A1 Methods and compositions for oral administration of proteins |